Molina Healthcare (NYSE:MOH) Hits New 1-Year Low – Should You Sell?

Molina Healthcare, Inc. (NYSE:MOH) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $282.45 and last traded at $282.86, with a volume of 374071 shares. The stock had previously closed at $286.60.

Wall Street Analyst Weigh In

Several brokerages recently commented on MOH. Wells Fargo & Company upped their target price on Molina Healthcare from $315.00 to $360.00 and gave the company an “equal weight” rating in a report on Monday, August 5th. JPMorgan Chase & Co. lowered their target price on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating for the company in a research note on Wednesday, July 10th. StockNews.com raised shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday. Deutsche Bank Aktiengesellschaft lowered their price objective on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research report on Monday, July 29th. Finally, Jefferies Financial Group cut their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a research report on Wednesday, July 24th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $378.00.

Molina Healthcare Stock Performance

The stock has a market cap of $16.64 billion, a price-to-earnings ratio of 15.55, a P/E/G ratio of 1.15 and a beta of 0.58. The company’s fifty day simple moving average is $338.57 and its two-hundred day simple moving average is $331.56. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.73 by $0.13. The business had revenue of $9.88 billion during the quarter, compared to the consensus estimate of $9.75 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The company’s quarterly revenue was up 18.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.65 EPS. On average, analysts forecast that Molina Healthcare, Inc. will post 23.5 earnings per share for the current year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the transaction, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the transaction, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the sale, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by company insiders.

Institutional Investors Weigh In On Molina Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. Innealta Capital LLC bought a new position in shares of Molina Healthcare during the 2nd quarter valued at about $36,000. Ashton Thomas Private Wealth LLC purchased a new stake in Molina Healthcare in the second quarter worth approximately $40,000. AM Squared Ltd bought a new position in Molina Healthcare during the second quarter valued at approximately $59,000. UMB Bank n.a. raised its stake in shares of Molina Healthcare by 96.2% during the third quarter. UMB Bank n.a. now owns 206 shares of the company’s stock worth $71,000 after acquiring an additional 101 shares in the last quarter. Finally, Fidelis Capital Partners LLC bought a new stake in shares of Molina Healthcare in the 1st quarter worth approximately $151,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.